Eduardo Díaz-Rubio Selected Research

Eduardo Díaz-Rubio Research Topics

Disease

40	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2002
27	Neoplasms (Cancer) 01/2021 - 05/2002
14	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2005
7	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2002
6	Disease Progression 02/2013 - 06/2004
5	Colonic Neoplasms (Colon Cancer) 11/2018 - 06/2004
5	Diarrhea 01/2012 - 09/2007
4	Circulating Neoplastic Cells 01/2019 - 11/2006
4	Hand-Foot Syndrome 01/2012 - 09/2007
4	Neutropenia 04/2008 - 06/2004
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 05/2007
2	Rectal Neoplasms (Rectal Cancer) 11/2018 - 01/2016
2	Microsatellite Instability 01/2018 - 07/2002
2	Hemorrhage 01/2015 - 04/2012
2	Sarcoma (Soft Tissue Sarcoma) 04/2014 - 08/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2014 - 07/2009
2	Carcinogenesis 10/2007 - 11/2006
2	Neoplasm Micrometastasis 09/2006 - 01/2005
1	Pain (Aches) 01/2021
1	Adenocarcinoma 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Genomic Instability 02/2014
1	Adenocarcinoma of Lung 02/2014
1	Osteosarcoma (Osteogenic Sarcoma) 02/2014
1	Fibrosis (Cirrhosis) 02/2013
1	Hepatocellular Carcinoma (Hepatoma) 02/2013
1	Thrombosis (Thrombus) 05/2012
1	Solitary Kidney 04/2012
1	Hematoma 04/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2012
1	Paronychia 01/2012

Drug/Important Bio-Agent (IBA)

15	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 10/2002
14	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 08/2003
10	Capecitabine (Xeloda)FDA Link 05/2014 - 06/2004
9	XELOXIBA 01/2012 - 06/2004
8	Irinotecan (Camptosar)FDA LinkGeneric 11/2020 - 08/2003
8	Bevacizumab (Avastin)FDA Link 11/2020 - 01/2005
7	Cetuximab (Erbitux)FDA Link 01/2019 - 11/2007
7	ErbB Receptors (EGF Receptor)IBA 01/2019 - 11/2007
6	Leucovorin (Folinic Acid)FDA Link 11/2020 - 01/2007
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2002
5	Trastuzumab (Herceptin)FDA Link 10/2014 - 10/2005
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 08/2010
3	Biological ProductsIBA 01/2021 - 10/2009
3	EnzymesIBA 01/2020 - 03/2012
3	PlatinumIBA 01/2019 - 10/2002
3	Codon (Codons)IBA 01/2019 - 12/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2011
3	thiamine triphosphorate (TTP)IBA 09/2007 - 06/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 01/2005
2	AntioxidantsIBA 01/2020 - 01/2018
2	Superoxide DismutaseIBA 01/2020 - 01/2018
2	TrabectedinIBA 01/2019 - 05/2007
2	Pharmaceutical PreparationsIBA 01/2018 - 12/2008
2	AntibodiesIBA 04/2014 - 09/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2014 - 10/2009
2	Monoclonal AntibodiesIBA 12/2012 - 08/2010
2	Sunitinib (Sutent)FDA Link 04/2012 - 01/2010
2	LigandsIBA 08/2010 - 10/2002
2	Gemcitabine FDA Link 12/2009 - 08/2002
2	Transaminases (Aminotransferases)IBA 05/2009 - 05/2007
1	ChemokinesIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	adhesion receptorIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2019
1	antiarrhythmic peptide (AAP)IBA 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	Dihydrotachysterol (AT 10)IBA 12/2018
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Circulating Tumor DNAIBA 01/2017
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2016
1	Vitamin D-Binding ProteinIBA 01/2016
1	EpiregulinIBA 12/2015
1	Formaldehyde (Formol)FDA Link 12/2015
1	ParaffinIBA 12/2015
1	Messenger RNA (mRNA)IBA 12/2015
1	AmphiregulinIBA 12/2015
1	pazopanib FDA Link 01/2015
1	Lapatinib (GW572016)FDA Link 10/2014
1	human ERBB2 proteinIBA 10/2014
1	Sorafenib (BAY 43-9006)FDA Link 02/2013
1	Blood Proteins (Serum Proteins)IBA 05/2012
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 05/2012
1	AnthracyclinesIBA 03/2012

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 01/2022 - 05/2005
22	Therapeutics 01/2022 - 06/2004
3	Adjuvant Chemotherapy 01/2016 - 07/2009
2	Neoadjuvant Therapy 01/2016 - 08/2009
2	Aftercare (After-Treatment) 01/2015 - 01/2008
1	Immunotherapy 01/2020
1	Salvage Therapy 01/2019
1	Palliative Care (Palliative Therapy) 01/2016
1	Radiotherapy 01/2015